# Chinook Therapeutics (stock symbol: KDNY) Logo in transparent PNG and SVG formats

## Chinook Therapeutics Logo large

### Chinook Therapeutics Logo large Download PNG (33.61 KB)

![Chinook Therapeutics Logo large Download PNG (33.61 KB)](/img/orig/KDNY_BIG-998eadac.png)

### Chinook Therapeutics Logo large Download SVG (16.42 KB)

![Chinook Therapeutics Logo large Download SVG (16.42 KB)](/img/orig/KDNY_BIG-046693f3.svg)

## Chinook Therapeutics Logo icon format

### Chinook Therapeutics Logo icon format Download PNG (31.13 KB)

![Chinook Therapeutics Logo icon format Download PNG (31.13 KB)](/img/orig/KDNY-389235ef.png)

### Chinook Therapeutics Logo icon format Download SVG (5.38 KB)

![Chinook Therapeutics Logo icon format Download SVG (5.38 KB)](/img/orig/KDNY-72291fdc.svg)

## Chinook Therapeutics Logo large for dark backgrounds

### Chinook Therapeutics Logo large for dark backgrounds Download PNG (33.45 KB)

![Chinook Therapeutics Logo large for dark backgrounds Download PNG (33.45 KB)](/img/orig/KDNY_BIG.D-7ddf5e84.png)

### Chinook Therapeutics Logo large for dark backgrounds Download SVG (16.42 KB)

![Chinook Therapeutics Logo large for dark backgrounds Download SVG (16.42 KB)](/img/orig/KDNY_BIG.D-37e3b763.svg)

## About Chinook Therapeutics

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington.

1. Website domain: chinooktx.com
2. Employees: 138
3. Marketcap: $1.32 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
